Publications by authors named "Philip Laws"

Claim this Profile
F
FIB-4 as an effective screening tool in psoriatic arthritis patients at high-risk for liver disease: a cross-sectional study using FibroScan.
Katya Meridor, Stephanie R Harrison, Richard Parker, Chenchu Chimakurthi, Philip M Laws

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitis.
Katya Meridor, Sook Yan Lee, Ilona Blee, Jane E Freeston, Philip M Laws

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort.
Oras A Alabas, Ian Evans, Kathleen Mcelhone, Zenas Z N Yiu, Nick J Reynolds, Philip Laws

Clin Exp Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis.
Zenas Z N Yiu, Catherine H Smith, Philip Laws, Philip J Hampton, Christopher E M Griffiths

JAMA Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar rates of new psoriatic arthritis diagnoses in a dedicated psoriatic disease triage clinic, regardless of referral route.
Katya Meridor, Stephanie R Harrison, Gabriele De Marco, Kave Shams, Philip M Laws

Rheumatol Adv Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive Study.
Ulrich Mrowietz, Rachel Sommer, Sascha Gerdes, Ziad Reguiai, Wolfgang Weger, Philip M Laws

Psoriasis (Auckl)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis.
Duc Binh Phan, Anthony P Bewley, Philip Laws, Teena Mackenzie, Catherine H Smith

JAMA Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study.
Stephanie R Harrison, Fiona Campbell, Hannah Bennett, Gabriele De Marco, Philip S Helliwell, Philip M Laws

Br J Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024.
Michael R Ardern-Jones, Sara J Brown, Carsten Flohr, Parwez Hossain, Alan D Irvine, Philip Laws

Br J Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
Fiona Campbell, Philip Laws

Br J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.
Md Yuzaiful Md Yusof, Eve M D Smith, Sammy Ainsworth, Kate Armon, Michael W Beresford, Philip M Laws

Rheumatol Adv Pract· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers.
Lucy M Carter, Zoe Wigston, Philip Laws, Edward M Vital

Br J Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, Philip J Hampton, Nick J Reynolds, Philip M Laws

Br J Dermatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study).
Matthias Augustin, Rachel Sommer, Esteban Daudén, Philip Laws, Elke de Jong

BMJ Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis.
Zenas Z N Yiu, Gabrielle Becher, Brian Kirby, Philip Laws, Nick J Reynolds

JAMA Dermatol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases.
Sinisa Savic, James Coe, Philip Laws

J Invest Dermatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase).
Richard B Warren, Michael Gold, Melinda Gooderham, Leon H Kircik, Jean-Philippe Lacour, Philip Laws

J Drugs Dermatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.
Tim Raine, Maria Angeliki Gkini, Peter M Irving, Arvind Kaul, Eleanor Korendowych, Philip Laws

BioDrugs· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving patient care through a collaborative effort in the Leeds Combined Psoriatic Service: an effective provision of multi-specialty input.
Claire Y Vandevelde, Kate Harnden, Jane Freeston, Andrew Barr, Christian P Selinger, Philip Laws

Rheumatology (Oxford)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Pre-Clinical Psoriatic Arthritis in an Integrated Dermato-Rheumatology Environment.
Laura Savage, Ilaria Tinazzi, Alen Zabotti, Philip M Laws, Miriam Wittmann

J Clin Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Localized Cutaneous Amyloidosis Affecting Female Individuals of a Pakistani Pedigree.
Bevin Bhoyrul, Alicia Ng, Philip M Laws, Bipin Mathew, Sangeetha Shanmugam

Am J Dermatopathol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
Charlie Bridgewood, Gareth W Fearnley, Anna Berekmeri, Philip Laws, Tom Macleod

Front Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema.
Anna Berekméri, Anne Latzko, Adewonuola Alase, Tom Macleod, Joseph S Ainscough, Philip Laws

J Allergy Clin Immunol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A striking case of dermatosis neglecta.
Bevin Bhoyrul, Mark Jd Goodfield, Philip M Laws

Int Wound J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Squamous Cell Carcinoma Developing Within a Red-Ink Tattoo.
Sara Sherif, Elizabeth Blakeway, Chris Fenn, Alyn German, Philip Laws

J Cutan Med Surg· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis